DAA497 |
ubiquinol-cytochrome c reductase core protein II |
Molecular |
skeletal muscle |
Human |
UQCRC2 |
3.0% Decrease Gene Expression Level |
|
DAA556 |
ubiquinol-cytochrome c reductase complex (7.2 kD) |
Molecular |
skeletal muscle |
Human |
UCRC |
2.0% Decrease Gene Expression Level |
|
DAA510 |
U2 small nuclear RNA auxiliary factor 1 |
Molecular |
skeletal muscle |
Human |
U2AF1 |
3.0% Increase Gene Expression Level |
|
DAA252 |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide |
Molecular |
brain |
Human |
YWHAZ |
10.0% Decrease Gene Expression Level |
|
DAA277 |
tyrosinase-related protein 1 |
Molecular |
kidney |
Human |
TYRP1 |
21.0% Decrease Gene Expression Level |
|
DAA2417 |
tumor suppressing subtransferable candidate 5 increases with age |
Molecular |
dermis |
Human |
SLC22A18 |
16.9% Increase DNA Methylation |
|
DAA241 |
tumor necrosis factor receptor superfamily, member 21 |
Molecular |
brain |
Human |
TNFRSF21 |
18.0% Decrease Gene Expression Level |
|
DAA2457 |
tumor necrosis factor receptor superfamily; member 17 increases with age |
Molecular |
mesenchymal stem cell |
Human |
TNFRSF17 |
18.8% Increase DNA Methylation |
|
DAA2408 |
tumor necrosis factor receptor superfamily; member 17 decreases with age |
Molecular |
dermis |
Human |
TNFRSF17 |
17.6% Decrease DNA Methylation |
|
DAA416 |
tubulin polymerization-promoting protein family member 3 |
Molecular |
skeletal muscle |
Human |
TPPP3 |
48.0% Increase Gene Expression Level |
|
DAA243 |
tubulin polymerization promoting protein |
Molecular |
brain |
Human |
TPPP |
21.0% Decrease Gene Expression Level |
|
DAA2117 |
TSPY-like 5 decreases with age |
Molecular |
ovary |
Human |
TSPYL5 |
45.4% Decrease Gene Expression Level |
|
DAA244 |
TSPY-like 2 |
Molecular |
brain |
Human |
TSPYL2 |
14.0% Decrease Gene Expression Level |
|
DAA2099 |
tropomodulin 3 (ubiquitous) decreases with age |
Molecular |
ovary |
Human |
TMOD3 |
35.9% Decrease Gene Expression Level |
|
DAA242 |
trophoblast glycoprotein |
Molecular |
brain |
Human |
TPBG |
13.0% Decrease Gene Expression Level |
|
DAA324 |
tRNA methyltransferase 11-2 homolog (S. cerevisiae) |
Molecular |
skeletal muscle |
Human |
TRMT112 |
4.0% Increase Gene Expression Level |
|
DAA566 |
TRM5 tRNA methyltransferase 5 homolog (S. cerevisiae) |
Molecular |
skeletal muscle |
Human |
TRMT5 |
2.0% Increase Gene Expression Level |
|
DAA205 |
tripartite motif-containing 27 |
Molecular |
brain |
Human |
TRIM27 |
5.0% Decrease Gene Expression Level |
|
DAA583 |
tripartite motif-containing 15 |
Molecular |
skeletal muscle |
Human |
TRIM15 |
18.0% Increase Gene Expression Level |
|
DAA2093 |
TRIO and F-actin binding protein increases with age |
Molecular |
ovary |
Human |
TRIOBP |
73.0% Increase Gene Expression Level |
|
DAA699 |
Triglyceride levels increase |
Physiological |
plasma |
Human |
— |
— |
|
DAA904 |
Transport maximum for glucose declines |
Physiological |
renal tubule |
Human |
— |
— |
|
DAA1067 |
transporter activity decreases |
Molecular |
blood brain barrier |
Human |
— |
— |
|
DAA2030 |
Transmission of visible light through eye lenses decreases |
Physiological |
lens |
Human |
— |
— |
|
DAA537 |
transmembrane protein 59-like |
Molecular |
skeletal muscle |
Human |
TMEM59L |
8.0% Decrease Gene Expression Level |
|